fda tirzepatide update today approval for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly FDA reconsidering its decision to

PubMed Yan, F

They also possess antithrombotic properties that can be leveraged with complementary medications used in patients with coronary artery disease, including those with prior events

Questions to ask your provider Before your first injection, get clear answers to these questions

If you fast on certain days, timing your injection so that peak suppression does not overlap with your feeding window helps ensure adequate nutrition

The amount of weight lost varies between individuals, but studies have shown significant weight loss in participants using Ozempic combined with lifestyle interventions like diet and exercise

A similar medication called Wegovy with the same active ingredient, semaglutide, is approved for weight loss and obesity